Niacin cholesterol lowering intervention

Lithium Nicotinate - Enduracin - Wampocap - Nicotinate - Nicolar - Nicocap - Nicobid - Nico400 - Nico 400 - Nico-400 - Nicamin - Induracin - 3 Pyridinecarboxylic Acid - 3-Pyridinecarboxylic Acid - Nicotinic Acid - Niacin

Trial	Studied treatment	Control	Patients	Size	Study type	Results	NCT
Cardiovascular prevention - cholesterol lowering intervention in all chronical situations - cholesterol lowering intervention in patients with prior MI or with CHD - niacin in all type of patients - HDL increasing drugs in all type of patients
Carlson (Stockholm), 1977	clofibtate+niacin	placebo	secondary prevention	555 (279/276)	Confirmatory -
CLAS, 1987	colestipol-niacin	placebo	Peripheral Arterial Disease	188 (94/94)	Exploratory
CLAS, 1987	colestipol-niacin	placebo	secondary prevention	NA	Exploratory
VA drugs, 1968	niacin	control		220 (77/143)	Confirmatory
ARBITER 6-HALTS (niacin vs ezetimibe), 2009	niacin	ezetimibe		208 (97/111)	Exploratory		NCT00397657
CDP niacin, 1975	niacin	placebo		3908 (1119/2789)	Confirmatory
AIM-HIGH, 2011	niacin	placebo (on top statin)		3409 (1718/1691)	Confirmatory		NCT00120289
HPS 2-Thrive	niacin	placebo (on top statin)		25673 (12838/12835)	Confirmatory		NCT00461630
Oxford Niaspan Study, 2009	niacin	placebo (on top statin)		71 (35/36)	Exploratory		NCT00232531
ARBITER 2, 2009	niacin	placebo (on top statin)		167 (87/80)	Exploratory
HATS, 2001	niacin	placebo (on top statin)		146 (73/73)	Confirmatory -
UCSF SCOR, 1990	niacin+colestipol	control		72	Exploratory
FATS, 1990	niacin+colestipol	placebo		102 (48/54)
Guyton, 2008	niacin+ezetimibe	simvastatin+ezetimibe		NA	Exploratory
Peripheral vascular diseases - cholesterol lowering intervention in all type of patients
CLAS, 1987	colestipol-niacin	placebo	Peripheral Arterial Disease	188 (94/94)	Exploratory
Post myocardial infarction - cholesterol lowering intervention in all type of patients
Carlson (Stockholm), 1977	clofibtate+niacin	placebo	secondary prevention	555 (279/276)	Confirmatory -